Log inSign up
AAOIFI No. 21 screening

Is TRAX halal?

First Tracks Biotherapeutics, I

Doubtful

No clear verdict is possible for First Tracks Biotherapeutics, I — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 15 October 2026

Exchange

NASDAQ

Price

34.46

Day

-4.38%

Market cap

$1.23B

Industry

Biotechnology

Sector

Healthcare

What the company does

First Tracks Biotherapeutics (IPO 2026) develops immunology drugs (ANB033, rosnilimab, ANB101) for autoimmune and inflammatory diseases, in clinical trials. No revenue.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ current market cap $1.23B = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $168.02M ÷ current market cap $1.23B = 13.6%

    13.6%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

For information (AAOIFI 3/1 note): cash + receivables are 94.5% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.